Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental data
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental data
Authors
Keywords
Vascular tumour growth, Continuous model, Dynamical system, Antiangiogenic treatment, In silico oncology, Computational oncology
Journal
Biology Direct
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-22
DOI
10.1186/s13062-016-0114-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Implications from Sensitivity Analysis of Tumor Angiogenesis Models
- (2015) Jan Poleszczuk et al. PLoS One
- Recent Advances in Anti-Angiogenic Therapy of Cancer
- (2015) Rajeev S. Samant et al. Oncotarget
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- Model-based angiogenic inhibition of tumor growth using modern robust control method
- (2014) Levente Kovács et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Mesoscopic and continuum modelling of angiogenesis
- (2014) F. Spill et al. JOURNAL OF MATHEMATICAL BIOLOGY
- Joining forces of Bayesian and frequentist methodology: a study for inference in the presence of non-identifiability
- (2013) A. Raue et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES
- The Technologically Integrated Oncosimulator: Combining Multiscale Cancer Modeling With Information Technology in the In Silico Oncology Context
- (2013) Georgios Stamatakos et al. IEEE Journal of Biomedical and Health Informatics
- Pharmacokinetics, Lymph Node Uptake, and Mechanistic PK Model of Near-Infrared Dye-Labeled Bevacizumab After IV and SC Administration in Mice
- (2012) Fang Wu et al. AAPS Journal
- Likelihood based observability analysis and confidence intervals for predictions of dynamic models
- (2012) Clemens Kreutz et al. BMC Systems Biology
- Enhancement of radiation response with bevacizumab
- (2012) Tien Hoang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy
- (2011) Yasufumi Sato CANCER SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Identifiability and observability analysis for experimental design in nonlinear dynamical models
- (2011) A. Raue et al. CHAOS
- Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells
- (2011) L. von Baumgarten et al. CLINICAL CANCER RESEARCH
- A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology
- (2011) Sébastien Benzekry et al. COMPTES RENDUS MATHEMATIQUE
- Multi-input Optimal Control Problems for Combined Tumor Anti-angiogenic and Radiotherapy Treatments
- (2011) U. Ledzewicz et al. JOURNAL OF OPTIMIZATION THEORY AND APPLICATIONS
- Periodic solutions of angiogenesis models with time lags
- (2011) P. Amster et al. NONLINEAR ANALYSIS-REAL WORLD APPLICATIONS
- Exploiting Clinical Trial Data Drastically Narrows the Window of Possible Solutions to the Problem of Clinical Adaptation of a Multiscale Cancer Model
- (2011) Georgios S. Stamatakos et al. PLoS One
- Multiscale Modelling of Vascular Tumour Growth in 3D: The Roles of Domain Size and Boundary Conditions
- (2011) Holger Perfahl et al. PLoS One
- Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma
- (2010) Pierre-Yves Salaun et al. CANCER
- An advanced discrete state–discrete event multiscale simulation model of the response of a solid tumor to chemotherapy: Mimicking a clinical study
- (2010) G.S. Stamatakos et al. JOURNAL OF THEORETICAL BIOLOGY
- Chemotherapy of vascularised tumours: Role of vessel density and the effect of vascular “pruning”
- (2010) Alberto d’Onofrio et al. JOURNAL OF THEORETICAL BIOLOGY
- An Enzyme-Linked Immunosorbent Assay to Study Bevacizumab Pharmacokinetics
- (2010) David Ternant et al. THERAPEUTIC DRUG MONITORING
- Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood
- (2009) A. Raue et al. BIOINFORMATICS
- A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy
- (2009) Frédérique Billy et al. JOURNAL OF THEORETICAL BIOLOGY
- Nonlinear modelling of cancer: bridging the gap between cells and tumours
- (2009) J S Lowengrub et al. NONLINEARITY
- Cell killing and resistance in pre-operative breast cancer chemotherapy
- (2008) Paolo Ubezio et al. BMC CANCER
- Clinical pharmacokinetics of bevacizumab in patients with solid tumors
- (2008) Jian-Feng Lu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- VEGF and angiogenesis: implications for breast cancer therapy
- (2008) Joachim Drevs EJC SUPPLEMENTS
- A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy
- (2008) A. D'Onofrio et al. MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA
- Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis
- (2007) Muthu Selvakumaran et al. BIOCHEMICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started